Prospect: Information for the user
(micofenolato mofetilo)
Read this prospect carefully before starting to take the medicine, because it contains important information for you
|
6. Contentsof the package and additional information
The Micofenolato mofetilo tablets are used to prevent the body from rejecting a kidney, heart or liver transplant. It is an immunosuppressant medication used to suppress rejection in an organ transplant, reducing the activity of the immune system.
This medication is used in combination with other medications known as ciclosporina and corticosteroids.
?Do not takemicofenolato mofetilo Normon:
?Warnings and precautions
Consult your doctor immediately before taking Micofenolato mofetilo Normon:
-If you experience any indication of infection (e.g. fever, sore throat), cardenals not caused by a blow and/or unexpected bleeding, as this medication may suppress your immune system and make you more susceptible to infections, such as skin, mouth, respiratory tract, stomach and intestinal, lung, and urinary tract infections.
-If you have, or have had in the past, any digestive system problems, for example, stomach ulcers.
-If you are planning to become pregnant, or have become pregnant during treatment with this medication.
This medication reduces your body's defenses. As a result, there is a greater risk of developing skin cancer. Limit the amount of sunlight and UV light you absorb by:
-Wearing appropriate clothing that protects you and also covers your head, neck, arms, and legs.
-Using a high-protection sunscreen cream.
?Taking Micofenolato mofetilo Normon with other medications
Inform your doctor or pharmacist if you are using or have recently used other medications, including those purchased without a prescription, as this medication may affect how other medications work. Also, other medications may affect how Micofenolato mofetilo works. Especially:
Vaccines: If you need to be vaccinated(live vaccines), during treatment withthis medication, consult your doctor or pharmacist. Your doctor will advise on the vaccine that can be given to you
Do not donate blood during treatment with this medication and at least 6 weeks after completing treatment. Men should not donate semen during treatment with this medication and at least 90 days after completing treatment.
?Taking Micofenolato mofetilo Normon with food and drinks
The taking of food and drinks does not affect your treatment with this medication.
?Pregnancy, fertility, and breastfeeding
Contraception in women taking Micofenolato mofetilo Normon
If you are a woman who can become pregnant, you must always use two effective contraceptive methods. This includes:
Consult your doctor to see which contraceptive method is most suitable for you. This will depend on your individual situation. It is recommended to use two contraceptive methods as this will reduce the risk of unintended pregnancy.Consult your doctor as soon as possible if you believe your contraceptive method may not have been effective or if you have forgotten to take the contraceptive pill.
You are considered not susceptible to becoming pregnant if your case is one of the following:
Contraception in men taking Micofenolato mofetilo Normon
The available evidence does not indicate a higher risk of malformations or spontaneous abortion if the father takes micofenolato. However, the risk cannot be completely ruled out. As a precaution, it is recommended that you or your female partner use a reliable contraceptive method during treatment and for 90 days after stopping this medication.
If you are planning to have a child, consult your doctor about the possible risks.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or believe you may be pregnant, consult your doctor or pharmacist before taking this medication. Your doctor will discuss the risks and alternative treatment options that you can take to prevent organ transplant rejection if:
If you become pregnant during treatment with micofenolato, inform your doctor immediately. However, continue taking Micofenolato mofetilo until you see your doctor.
Pregnancy
Micofenolato mofetilo causes a very high frequency of spontaneous abortions (50%) and severe damage to the unborn baby (23-27%). Among the malformations that have been reported are ear, eye, facial (cleft lip and palate), finger development, heart, esophagus (tube connecting the throat to the stomach), kidney, and nervous system (e.g. spina bifida) abnormalities. Your baby may be affected by one or more of these.
If you are a woman who can become pregnant, you must have a negative result on a pregnancy test before starting treatment and follow the contraceptive advice provided by your doctor. Your doctor may request multiple pregnancy tests to ensure you are not pregnant before starting treatment.
Breastfeeding
Do not take this medication if you are breastfeeding. This is because small amounts of the medication may pass into breast milk.
?Driving and operating machinery
This medication is unlikely to affect your ability to drive or operate machinery.
Micofenolato mofetilo Normon contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially “sodium-free”.
Follow exactly the administration instructions of this medication as indicated by your doctor. Consult your doctor or pharmacist if you have any doubts.
Amount to take
The amount you need to take depends on the type of transplant you have. The usual doses are shown below. Treatment will continue until it is necessary to prevent rejection of the transplanted organ.
Kidney transplant
Adults:The first dose should be administered within 72 hours after the transplant surgery. The recommended daily dose is 4 tablets (2 gof active principle), administered in 2 separate doses. This means taking 2 tablets in the morning and other 2 tablets at night.
Children (between 2 and 18 years):The dose varies according to the child's height. The doctor will decide which is the most suitable dose taking into account the body surface (weight and height). The recommended dose is 600 mg/m2, administered twice a day.
Heart transplant
Adults:The first dose should be administered within 5 days after the transplant surgery. The recommended daily dose is 6 tablets (3 gof active principle), administered in two separate doses. This means taking 3 tablets in the morning and other 3 tablets at night.
Children:No data are available to recommend the use of this medication in children who have received a heart transplant.
Liver transplant:
Adults:The first dose should be administered once the operation has been performed, at least 4 days after, and when able to take oral medication. The recommended daily dose is 6 tablets (3 gof active principle), administered in two separate doses. This means taking 3 tablets in the morning and other 3 tablets at night.
Children:No data are available to recommend the use of this medicationin children who have received a liver transplant.
Taking this medication
Swallow the tablets whole with a glass of water. Do not break or crush them.
If you take moremicofenolato mofetilo Normonthan you should
If you take more Micofenolato mofetilo Normonthan you should, consult your doctor or go to the hospital immediately. Do this also if someone accidentally takes your medication. Bring the packaging of the medication with you.
If you forget to takemicofenolato mofetilo Normon
If you ever forget to take the medication, take it as soon as you remember. Then continue taking it at the usual hours. Do not take a double dose to make up for the missed doses.
If you interrupt the treatment withmicofenolato mofetilo Normon
Do not stop taking this medicationunless your doctor tells you to. If you interrupt the treatment, you may increase the risk of rejection of the transplanted organ.
If you have any other doubts about the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicinemay cause side effects, although not everyone will experience them.
Consult your doctor immediately if you notice any of the following severe side effects, as you may need urgent medical treatment:
• if you have symptoms of infection such as fever or sore throat
• if you develop petechiae or unexpected bleeding
• if you have a rash, facial swelling, lip, tongue, or throat swelling with difficulty breathing. You may be experiencing a severe allergic reaction to the medicine (such as anaphylaxis, angioedema).
Common problems
Some of the most common problems are diarrhea, decreased white blood cell or red blood cell count in the blood, infection, and vomiting. Your doctor will perform regular blood tests to record any changes:
Side effects are more likely to occur in children than in adults. These include diarrhea, infections, and decreased white blood cell and red blood cell counts in the blood.
Fighting infections
The treatment withmicofenolato mofetilo reduces the body's defenses. This is to prevent transplant rejection. For this reason, the body cannot fight infections as effectively as in normal conditions. This means you may contract more infections than usual. These include infections affecting the brain, skin, mouth, stomach, and intestines, lungs, and urinary system.
Skin and lymphatic cancer
As occurs in patients treated with other immunosuppressants, a very small number of patients treated with this medicine have developed skin and lymphoid tissue cancer.
Unwanted general effects
You may experience general side effects that affect your entire body. These include severe allergic reactions (such as anaphylaxis, angioedema), fever, feeling extremely tired, difficulty sleeping, pain (such as stomach pain, chest pain, joint or muscle pain, pain while urinating), headache, flu-like symptoms, and swelling.
Other adverse reactions may be:
Skin problemssuch as: acne, cold sores, shingles, skin growth, hair loss, skin rash, itching.
Urinary problemssuch as: kidney problems or frequent urination.
Digestive system and mouth problemssuch as constipation, nausea, indigestion, loss of appetite, flatulence, pancreatitis, colon or stomach inflammation, intestinal disorders including bleeding, liver problems, swollen gums, and mouth ulcers.
Nervous system problemssuch as: dizziness, drowsiness, numbness, seizures, tremors, vertigo, muscle spasms, anxiety or depression, mood or thought changes.
Cardiovascular and vascular problemssuch as: changes in blood pressure, abnormal heart rhythm, and blood vessel dilation.
Pulmonary problemssuch as: pneumonia, bronchitis, difficulty breathing, cough,which may be due to bronchiectasis (a condition in which the airways are abnormally dilated) or pulmonary fibrosis (pulmonary scarring). Consult your doctor if you develop persistent cough or shortness of breath, fluid in the lung or thoracic cavity, nasal sinus problems.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus.You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Conserve below30°C. Conserve in the original packaging.
Keep out of the reach and sight of children.
Do not use this medicationafter the expiration date that appears on the packaging afterCad. The expiration date is the last day of the month indicated.
Medicines should not be thrown into the drains or trash.Deposit the packaging and medicines that you do not need at the SIGRE pointof the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines that you do not need. By doing so, you will help protect the environment.
Composition ofmicofenolato mofetilo Normon
The active ingredient is micofenolato de mofetilo. Each tablet contains 500 mg of micofenolato de mofetilo.
The excipients are:
Core:microcrystalline cellulose (E-460), povidone (E-1201), croscarmellose sodium, magnesium stearate (E-470b).
Coating:indigo blue lacquer (E-132), iron oxide red (E-172), hypromellose (E-464), titanium dioxide (E-171) and macrogol 6000.
Appearance of Micofenolato mofetilo Normon and packaging size
Pinkish-colored, elongated, and biconvex tablets.
Each package contains 50 tablets.
Micofenolato mofetilo Normon 250 mg film-coated tablets EFG.
Marketing authorization holder and responsible manufacturer
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 628760 Tres CantosMadrid (SPAIN)
Review date of this leaflet: March 2018
The detailed and updated information of this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.es/.
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.